Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis Vulgaris

NCT03806790 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

182

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis Vulgaris

Interventions

DRUG: LEO 90100 foam
DRUG: Dovobet® ointment

Sponsor

LEO Pharma